Neuraxis, Inc. (NRXS) Stock Analysis

Neuraxis, Inc. (NRXS) is a publicly traded company in the HEALTHCARE sector. It trades at $6.96, carries a market capitalization of $90.90M. This page summarizes the public market data, fundamentals, and frequently asked questions for NRXS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $6.96
• Market Cap: $90.90M
• EPS: $-0.80
• 52-Week High: $9.33
• 52-Week Low: $2.20

Market Sentiment

Neuraxis, Inc. currently has a Neutral sentiment score of -0.00.

About Neuraxis, Inc.

Neuraxis, Inc. is a pioneering medical technology company headquartered in Versailles, Indiana, focused on the development and commercialization of advanced neuromodulation therapy devices for various neurological conditions. With a strong emphasis on innovation, the company utilizes state-of-the-art technology and research to create therapeutic solutions that significantly enhance patient outcomes and overall quality of life. Neuraxis's dedication to meeting unmet medical needs positions it ...

GNG Research Analysis

GNG Research scores Neuraxis, Inc. (NRXS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NRXS.

Frequently Asked Questions

Does NRXS pay dividends?

Neuraxis, Inc. (NRXS) does not currently pay a regular dividend.

What is NRXS's market cap?

Neuraxis, Inc. (NRXS) has a market capitalization of $90.90M with a current stock price of $6.96.